Company
Johnson & Johnson MedTech
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
242
510(k), De Novo and PMA
Device trials
279
As lead sponsor, any status
Adverse event reports
69,080
Received Nov 1, 2025 to Nov 20, 2026
Recall records
1,343
One per recalled product
Johnson & Johnson MedTech is on our public-company list (ticker JNJ). Names searched as well: Ethicon, DePuy, Biosense Webster, Abiomed. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
JNJ
NYSE · JOHNSON & JOHNSON
Public float
$367.0B
Value of shares held by non-insiders on Jun 29, 2025
Revenue
$94.2B
Fiscal year ending Dec 28, 2025
Net income
$26.8B
Fiscal year ending Dec 28, 2025
R&D spending
$109M
Fiscal year ending Dec 28, 2025
Cash
$16.9B
As of Sep 27, 2026
Long-term debt
$35.8B
As of Sep 27, 2026
Shares outstanding
2407.3M
As of Oct 15, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2025 | – | – | $9.14B | – |
| 2024 | – | – | $6.66B | – |
| 2023 | $4.24B | – | – | – |
| 2022 | – | – | $5.0M | – |
| 2021 | – | – | $7.43B | – |
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
The 8 newest of 242 since 2015.
K254196 · Decided Sep 17, 2026 · 268 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
241 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Left Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive, not recruiting
NCT07943182 · 60 participants (planned) · Start Dec 3, 2024 · Primary completion Dec 2027
Device: Impella CP with SmartAssist; Impella 5.5 with SmartAssist · For: Cardiogenic Shock; Heart Failure; Acute Decompensated Heart Failure (ADHF) and 2 more
Sites: Phoenix, Arizona; Loma Linda, California; Los Angeles, California · 24 sites in all
278 more trials with a free account
Reports received
69,080
Received Nov 1, 2025 to Nov 20, 2026. Includes 16 of another or unstated type.
Malfunction reports
43,297
63% of reports
Injury reports
23,182
34% of reports
Death reports
2,585
3.7% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 3,525 | 1,354 | 44 | 0 |
| Jan 24 | 3,859 | 1,532 | 55 | 2 |
| Feb 24 | 4,291 | 1,906 | 58 | 0 |
| Mar 24 | 4,045 | 2,917 | 119 | 0 |
| Apr 24 | 4,055 | 2,677 | 47 | 0 |
| May 24 | 3,658 | 2,218 | 73 | 2 |
| Jun 24 | 3,828 | 1,839 | 81 | 2 |
| Jul 24 | 3,803 | 1,865 | 49 | 1 |
| Aug 24 | 4,185 | 3,770 | 636 | 0 |
| Sep 24 | 4,341 | 1,897 | 107 | 0 |
| Oct 24 | 4,924 | 2,487 | 325 | 3 |
| Nov 24 | 4,389 | 2,132 | 512 | 0 |
| Dec 24 | 3,659 | 1,820 | 135 | 1 |
| Jan 25 | 3,528 | 1,594 | 127 | 0 |
| Feb 25 | 2,738 | 1,326 | 97 | 0 |
| Mar 25 | 3,066 | 1,420 | 152 | 0 |
| Apr 25 | 3,507 | 1,851 | 168 | 0 |
| May 25 | 3,563 | 2,069 | 155 | 0 |
| Jun 25 | 3,483 | 2,416 | 219 | 0 |
| Jul 25 | 3,908 | 2,400 | 178 | 0 |
| Aug 25 | 3,171 | 1,334 | 105 | 0 |
| Sep 25 | 3,753 | 1,993 | 284 | 0 |
| Oct 25 | 3,514 | 1,821 | 232 | 0 |
| Nov 25 | 2,886 | 1,615 | 142 | 0 |
| Dec 25 | 4,059 | 1,959 | 184 | 0 |
| Jan 26 | 3,924 | 2,392 | 380 | 1 |
| Feb 26 | 3,215 | 2,544 | 471 | 0 |
| Mar 26 | 3,518 | 2,189 | 363 | 0 |
| Apr 26 | 4,099 | 2,133 | 185 | 0 |
| May 26 | 3,254 | 1,532 | 193 | 0 |
| Jun 26 | 4,295 | 1,643 | 191 | 0 |
| Jul 26 | 3,456 | 1,643 | 140 | 5 |
| Aug 26 | 3,653 | 1,950 | 154 | 10 |
| Sep 26 | 3,773 | 1,925 | 128 | 0 |
| Oct 26 | 3,165 | 1,657 | 54 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- IMPELLA9,708
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ETHILON Nylon Suture, Product Code 697GOpen, Classified
Z-0284-2027 · Started Sep 23, 2026 · Posted by FDA Oct 23, 2026
Reason given: Nylon suture indicated for use in general soft tissue approximation and/or ligation may have needles with distorted curvature, that may break during use, or could cause additional soft tissue or vessel injury, including tearing or bleeding intraoperatively.
Cause as FDA categorized it: Process control · Device type: Suture, Nonabsorbable, Steel, Monofilament And Multifilament, Sterile (GAQ)
1,342 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.